E. Evans

发表

Training medical myocologists in developing countries.

A. Chakrabarti, E. Evans, G. Bulmer, 2000, Medical mycology.

Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

F. Odds, M. Taylor, J. Wales, 1978, Journal of clinical pathology.

Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients.

F. Odds, E. Evans, 1980, Journal of clinical pathology.

Immunodiagnosis of invasive fungal infection.

L. Wheat, M. Richardson, E. Evans, 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis

M. Muers, R. Barton, E. Evans, 2000, Thorax.

Cystic fibrosis and allergic bronchopulmonary aspergillosis.

E. Evans, J. Littlewood, E. Simmonds, 1990, Archives of disease in childhood.

Purification and properties of cytochrome P-450-dependent 14 alpha-sterol demethylase from Candida albicans.

E. Evans, S. B. Brown, D. Adams, 1989, The Biochemical journal.

An investigation into the pathogenesis of vulvo-vaginal candidosis

R. Barton, E. Evans, H. Ashbee, 2001, Sexually transmitted infections.

Species Identification and Strain Differentiation of Dermatophyte Fungi by Analysis of Ribosomal-DNA Intergenic Spacer Regions

C. Jackson, R. Barton, E. Evans, 1999, Journal of Clinical Microbiology.

Spacer Regions Analysis of Ribosomal-DNA Intergenic Differentiation of Dermatophyte Fungi by Species Identification and Strain

C. Jackson, R. Barton, E. Evans, 1999 .

PCR fingerprinting Cryptococcus neoformans by random amplification of polymorphic DNA

E. Evans, R. Matthews, A. Crampin, 1993 .

Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group.

K. Tintelnot, M. Viviani, E. Chryssanthou, 2008, Medical mycology.

The effect of growth medium of filament production in Candida albicans.

K. T. Holland, F. Odds, M. Richardson, 1974, Sabouraudia.

Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy.

R. Hay, D. Denning, J. Cohen, 1997, The Journal of antimicrobial chemotherapy.

Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts.

M. Schaller, H. Korting, E. Evans, 2001, International journal of antimicrobial agents.

Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis.

E. Evans, J. Littlewood, E. Simmonds, 1994, Archives of disease in childhood.

Candida cell wall mannan in the vagina and its association with the signs and symptoms of vaginal candidosis.

E. Evans, P. Hunter, J. Clarke, 1991, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion.

Y. Chong, D. Gibbs, E. Evans, 2000, Diagnostic microbiology and infectious disease.

Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection.

R. Barton, E. Evans, L. Belkacemi, 1999, Medical mycology.

A study of the mechanism of quercetin oxygenation by 18O labelling. A comparison of the mechanism with that of haem degradation.

E. Evans, S. B. Brown, J. Holroyd, 1982, The Biochemical journal.

Enlarged cervical lymph node due to African histoplasmosis

E. Evans, R. Rivron, 1988, The Journal of Laryngology & Otology.

colonisation andpopulation density ofplace ofresidence incystic fibrosis

E. Evans, J. Littlewood, V. Hopwood, 1994 .

Multicenter evaluation of Microring YT, a new method of yeast identification

D. Warnock, M. Richardson, E. Evans, 1990, Journal of clinical microbiology.

A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations.

S. Senn, C. Viscoli, J. Cooke, 2003, Clinical therapeutics.

Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation

R. E. Warren, T. R. Rogers, C. C. Kibbler, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Fortnightly Review: Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology)

D. Denning, C. Kibbler, R. Warren, 1995, BMJ.

Tinea pedis: clinical experience and efficacy of short treatment.

E. Evans, 1997, Dermatology.

Comparison of terbinafine and clotrimazole in treating tinea pedis.

E. Evans, R. Bowen, G. J. Brown, 1993, BMJ.

Short‐duration therapy with terbinafine 1% cream in dermatophyte skin infections

I. James, E. Evans, R. Seaman, 1994, The British journal of dermatology.

Trichophyton tonsurans Tinea Capitis and Tinea Corporis: Treatment and Follow‐Up of Four Affected Family Members

E. Evans, J. Ravenscroft, M. Goodfield, 2000, Pediatric dermatology.

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.

J. Ólafsson, J. Steinsson, E. Evans, 2002, Archives of dermatology.

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis

B. Sigurgeirsson, E. Evans, 1999 .

Strain Identification of Trichophyton rubrum by Specific Amplification of Subrepeat Elements in the Ribosomal DNA Nontranscribed Spacer

S. Kelly, C. Jackson, R. Barton, 2000, Journal of Clinical Microbiology.

Molecular strain typing of Trichophyton rubrum indicates multiple strain involvement in onychomycosis

C. Jackson, R. Barton, E. Evans, 2003, The British journal of dermatology.

Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.

E. Evans, 1998, Journal of the American Academy of Dermatology.

The rationale for combination therapy

E. Evans, 2001, The British journal of dermatology.

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.

E. Evans, B. Sigurgeirsson, 1999, BMJ.

Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM).

T J Walsh, M G Rinaldi, R. Hay, 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Short term treatment of dermatophyte onychomycosis with terbinafine.

E. Evans, L. Andrew, M. Goodfield, 1992, BMJ.

Prediction of outcome in the treatment of onychomycosis

E. Evans, R. Sheehan-Dare, S. Sommer, 2003, Clinical and experimental dermatology.

Combined treatment with surgery and short duration oral antifungal therapy in patients with limited dermatophyte toenail infection

E. Evans, M. Goodfield, 2000 .

Treatment of dermatophyte infection of the finger‐ and toe‐nails with terbinafine (SF 86‐327, Lamisil), an orally active fungicidal agent

E. Evans, R. A. Forster, N. Rowell, 1989, The British journal of dermatology.

Use of terbinafine in HIV‐positive subjects: pilot studies in onychomycosis and oral candidiasis

D. Hawkins, M. Youle, E. Evans, 1996, The British journal of dermatology.

Medical mycology: a practical approach

E. Evans, M. Richardson, 1990 .

Laboratory methods for flucytosine (5-fluorocytosine)

R. Hay, F. Odds, D. Warnock, 1984 .

Mannan estimation as a measure of the growth of Candida albicans.

I. Pike, J. Carney, E. Evans, 1991, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Cytochrome P-450-dependent 14 alpha-demethylation of lanosterol in Candida albicans.

E. Evans, S. B. Brown, D. Adams, 1989, The Biochemical journal.

Restriction Fragment Length Polymorphism Analysis of Ribosomal DNA Intergenic Regions Is Useful for Differentiating Strains of Trichophyton mentagrophytes

S. Kelly, C. Jackson, R. Barton, 2003, Journal of Clinical Microbiology.

Vaginal yeasts in the era of “over the counter” antifungals

E. Evans, H. Ashbee, M. T. Reynolds, 2000, Sexually transmitted infections.

Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis.

E. Johnson, D. Warnock, E. Evans, 1995, Journal of clinical pathology.

Immunology of Diseases Associated with Malassezia Species

E. Evans, H. Ashbee, 2002, Clinical Microbiology Reviews.

Skin Colonization by Malassezia in Neonates and Infants

J. Puntis, E. Evans, H. Ashbee, 2002, Infection Control & Hospital Epidemiology.

Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream : a placebo controlled study

I. James, E. Evans, R. C. Joshipura, 1991 .

Candida strains from neonates in a special care baby unit.

F. Odds, E. Evans, A. M. Sharp, 1992, Archives of disease in childhood.

Detection of Aspergillus fumigatus PCR products by a microtitre plate based DNA hybridisation assay.

R. Barton, H. Fletcher, P. Verweij, 1998, Journal of Clinical Pathology.

A comparison of terbinafine (Lamisil®) 1% cream given for one week with clotrimazole (Canesten®) 1% cream given for four weeks, in the treatment of tinea pedis

E. Evans, 1994, The British journal of dermatology.

The incidence of pathogenic yeasts among open-heart surgery patients-the value of prophylaxis.

E. Evans, 1975, The Journal of thoracic and cardiovascular surgery.

Does naftifine have anti‐inflammatory properties? A double‐blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin

I. James, E. Evans, R. Seaman, 1993, The British journal of dermatology.

Clotrimazole (Canesten) in the treatment of candidal balanitis in men. With incidental observations on diabetic candidal balanoposthitis.

E. Evans, M. Waugh, K. Nayyar, 1978, The British journal of venereal diseases.

Intermittent local prophylaxis against recurrent vaginal candidosis.

J. Meaden, D. Warnock, E. Evans, 1988, Genitourinary medicine.

Resistance of the Candida albicans filamentous cycle to environmental change.

K. T. Holland, F. Odds, E. Evans, 1975, Sabouraudia.

Detection of Candida precipitins. a comparison of double diffusion and counter immunoelectrophoresis.

K. T. Holland, F. Odds, E. Evans, 1975, Journal of immunological methods.

*@ Topical terbinafine (Lamisil ) for superficial mycoses: High cure rates in short treatment times

E. Evans, 1998 .

One-week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1 % cream: a placebo-controlled study

E. Evans, J. Shah, R. C. Joshipura, 1992 .

Successful 2‐week treatment with terbinafine (Lamisil®) for moccasin tinea pedis and tinea manuum

E. Evans, P. Perkins, J. White, 1991, The British journal of dermatology.

Drug synergies and the potential for combination therapy in onychomycosis.

E. Evans, 2003, The British journal of dermatology.

Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.

David John Adams, K. Dickinson, E. Evans, 1990, The Biochemical journal.

Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents

B. Sigurgeirsson, E. Evans, C. Paul, 2002, The British journal of dermatology.

Use of slide latex agglutination test for rapid diagnosis of vaginal candidosis.

J. Carney, R. Rajakumar, E. Evans, 1987, Genitourinary medicine.

Antibodies to Candida after operations on the heart.

E. Evans, R. A. Forster, 1976, Journal of medical microbiology.

Scedosporium prolificans, a multi-resistant fungus, from a U.K. AIDS patient.

D. Denning, E. Evans, V. Hopwood, 1995, The Journal of infection.

Rapid diagnosis of vaginal candidosis by latex particle agglutination.

J. Carney, E. Evans, V. Hopwood, 1985, Journal of clinical pathology.

Relevance of Antigenicity of Candida Albicans Growth Phases to Diagnosis of Systemic Candidiasis

K. T. Holland, F. Odds, M. Richardson, 1973, British medical journal.

Training medical mycologists in developing countries

H. Gugnani, A. Chakrabarti, E. Evans, 2000 .

The identification of Candida albicans strains by restriction fragment length polymorphism analysis of DNA.

R. Smith, E. Evans, D. Adams, 1989, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Prevalence ofpathogenic yeasts andhumoral antibodies tocandida indiabetic patients

F. Odds, M. Taylor, J. Wales, 1978 .

A comparison of methods for the detection of Candida antigens. Evaluation of a new latex reagent.

J. Carney, E. Evans, V. Hopwood, 1985, Journal of immunological methods.

Identification and Purification of SpecificPenicillium marneffei Antigens and Their Recognition by Human Immune Sera

R. Hay, T. Sirisanthana, E. Evans, 1998, Journal of Clinical Microbiology.

Single strains of Trichophyton rubrum in cases of tinea pedis.

C. Jackson, R. Barton, E. Evans, 2005, Journal of medical microbiology.

Invasive aspergillosis in two patients with Pearson syndrome.

J. Meis, P. Verweij, E. Evans, 1999, The Pediatric infectious disease journal.

Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with AIDS.

E. Evans, S. Thomas, D. Hicks, 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

The oncogenic potential of Candida in the female genital tract

B. Wilkinson, C. Lacey, R. Walmsley, 1995, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The maintenance and preservation of fungi.

C. K. Campbell, E. Evans, D. Smith, 1989 .

A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion.

Y. Chong, D. Gibbs, E. Evans, 2000, Diagnostic microbiology and infectious disease.

Successful treatment of chronic tinea pedis and tinea manuum with Lamisil® (terbinafine)

E. Evans, P. Perkins, J. White, 1990 .

Serological tests in the diagnosis and prognosis of fungal infection in the compromised patient.

E. Evans, V. Hopwood, 1990 .

Post-traumatic fungal keratitis caused by Absidia corymbifera, with successful medical treatment

R. Barton, E. Evans, S. Narain, 2001, Eye.

Optimum conditions for initiation of filamentation in Candida albicans.

K. T. Holland, F. Odds, M. Richardson, 1975, Canadian journal of microbiology.